文献速递青光眼眼底病与葡萄膜炎

Sigma-1R在青光眼视神经夹伤模型中保护视网膜神经节细胞

Sigma-1R Protects Retinal Ganglion Cells in Optic Nerve Crush Model for Glaucoma.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2021-01-01

该研究在视神经夹伤(ONC)模型小鼠中探讨Sigma-1R(σ-1r)对视网膜神经节细胞(RGC)存活的影响及信号机制。通过AAV2-σ-1r载体增加σ-1r表达或使用σ-1r激动剂戊唑辛激活σ-1r,发现σ-1r激活或转基因表达可减轻ONC后RGC数量与功能下降,并抑制凋亡通路相关蛋白c-Jun、p-c-Jun和Caspase-3的表达。

要点

  • σ-1r敲除小鼠在ONC后RGC数量和功能下降较野生型更显著。
  • σ-1r激动剂戊唑辛或转基因过表达可增加ONC后RGC数量和活动。
  • ONC后c-Jun、p-c-Jun和Caspase-3表达随时间增加,戊唑辛治疗可减轻。

核心结论

  • 凋亡通路参与ONC模型中RGC丢失,σ-1r激活或转基因表达通过减轻凋亡通路恢复ONC后RGC数量和功能,发挥神经保护作用。

研究设计与样本

  • 研究在σ-1r敲除小鼠和野生型小鼠中诱导ONC损伤,使用AAV2-σ-1r载体增加σ-1r表达或使用σ-1r激动剂戊唑辛激活σ-1r,计数RGC。
  • 采用免疫组化和Western blot检测p-c-Jun、c-Jun和Caspase-3,采用模式视网膜电图(PERG)检测RGC活动。

主要发现

  • 戊唑辛处理的野生型小鼠与未处理野生型小鼠相比、野生型与σ-1r敲除小鼠相比,在无ONC时RGC计数和功能相似。
  • 戊唑辛诱导效应和σ-1r敲除效应仅在ONC后可观察到。
  • ONC导致野生型和σ-1r敲除小鼠RGC计数和活动下降,σ-1r敲除小鼠下降较野生型显著。
  • σ-1r转基因表达导致ONC后RGC计数和活动增加。
  • 野生型小鼠中戊唑辛治疗较未治疗野生型小鼠RGC计数和活动增加。

临床怎么用

  • σ-1r激活或过表达可能作为青光眼相关RGC损伤的潜在神经保护策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study was to determine the effects of the Sigma-1R (σ-1r) on retinal ganglion cell (RGC) survival following optic nerve crush (ONC) and the signaling mechanism involved in the σ-1r protection. METHODS: The overall strategy was to induce injury by ONC and mitigate RGC death by increasing σ-1r expression and/or activate σ-1r activity in σ-1r K/O mice and wild type (WT) mice. AAV2-σ-1r vector was used to increase σ-1r expression and σ-1r agonist used to activate the σ-1r and RGCs were counted. Immunohistochemical and Western blot analysis determined phosphorylated (p)-c-Jun, c-Jun, and Caspase-3. Pattern electroretinography (PERG) determined RGC activity. RESULTS: RGC counts and function were similar in pentazocine-treated WT mice when compared to untreated mice and in WT mice when compared with σ-1r K/O mice. Pentazocine-induced effects and the effects of σ-1r K/O were only observable after ONC. ONC resulted in decreased RGC counts and activity in both WT and σ-1r K/O mice, with σ-1r K/O mice experiencing significant decreases compared with WT mice. The σ-1r transgenic expression resulted in increased RGC counts and activity following ONC. In WT mice, treatment with σ-1r agonist pentazocine resulted in increased RGC counts and increased activity when compared with untreated WT mice. There were time-dependent increases in c-jun, p-c-jun, and caspase-3 expression in ONC mice that were mitigated with pentazocine-treatment. CONCLUSIONS: These findings suggest that the apoptotic pathway is involved in RGC losses seen in an ONC model. The σ-1r offers neuroprotection, as activation and/or transgenic expression of σ-1r attenuated the apoptotic pathway and restored RGCs number and function following ONC.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Li L, He S, Liu Y, et al. Sigma-1R Protects Retinal Ganglion Cells in Optic Nerve Crush Model for Glaucoma. Invest Ophthalmol Vis Sci. 2021. PMID: 34406331. doi:10.1167/iovs.62.10.17

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。